Loading…
Loading…
High-level medical, clinical development, and pharmaceutical consulting tailored to biotech and life sciences organizations.
Support clinical strategy, development planning, program execution, and cross-functional medical guidance. From early-phase through registration, Princeton MedSolutions provides the strategic medical perspective needed to advance programs efficiently and with scientific rigor.
Provide strategic medical affairs support, scientific communication guidance, and stakeholder engagement expertise. Dr. Meier brings executive-level medical affairs leadership to help organizations build credibility with key opinion leaders, payers, and regulatory bodies.
Offer medical monitoring support, trial oversight, protocol guidance, and clinical safety input for ongoing and planned clinical studies. Princeton MedSolutions supports sponsors with hands-on clinical safety oversight throughout the trial lifecycle.
Advise on development pathways, indication strategy, asset positioning, and informed decision-making across the product lifecycle. Dr. Meier helps organizations identify the most efficient path from discovery to approval — with practical experience in early access programs.
Support safety review, pharmacovigilance strategy, risk management, and clinical safety oversight throughout development and post-market. With formal pharmacovigilance training and clinical expertise, Dr. Meier provides rigorous safety support.
Provide executive-level medical leadership for emerging biotech companies needing senior expertise without a full-time internal CMO. Dr. Meier brings the credibility, experience, and strategic thinking needed to lead medical functions at the highest level.
Princeton MedSolutions partners with organizations across the pharmaceutical and biotech landscape.
Ready to explore how Princeton MedSolutions can support your pharmaceutical or clinical development program? Get in touch today.